Clinical Trial Update: Propionyl-L-Carnitine in Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Propionyl-L-Carnitine for Ulcerative Colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Propionyl-L-Carnitine (Propionyl-L-Carnitine)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED